OBIO Member: CCAB Signs Agreement with Pionyr Immunotherapeutics Inc.
OBIO Member, the Centre for the Commercialization of Antibodies and Biologics (CCAB)has signed an Agreement with Pionyr Immunotherapeutics Inc.
OBIO Member: Steadiwear Wins RESI on MaRS Innovation Challenge
OBIO Member, Steadiwear, has won 1st Place in the RESI on MaRS Innovation Challenge.
CAAP Companies: Pathcore & WinterLight Labs Announced as HTF Recipients
OBIO CAAP companies, Pathcore and WinterLight Labs have both been announced as recipients of the Ontario Health Technology Fund!
OBIO CAAP® 2017 Kicks Off Just As Toronto Health Innovation Week Launches
OBIO kicked off its 2017 Capital Access Advisory Program (CAAP®) on March 29, 2017, hosted at sponsor Norton Rose Fulbright LLP (NRF) Canada, just as Toronto’s first inaugural Health Innovation Week launches.
Call for Proposals: Hamilton Health Sciences & IBM
Hamilton Health Sciences and IBM are seeking proposals for exciting, innovative new projects aimed at improving the delivery of health care.
Pre-CAAP Company: MedStack Turns 2
OBIO Pre-CAAP company, MedStack, has turned 2!
CAAP Company: QoC Health Receives HTF from Province
OBIO CAAP 2016 company, QoC Health, with SMArTVIEW has been selected for one of 15 Ontario Health Technology Grants (HTF).
OBIO Partner: StarFish Medical Acquires Kangaroo Design
OBIO Partner, StarFish Medical has acquired Kangaroo Design of Toronto, the leading medical device development company in Ontario.
OBIO Member: CCAB Innovative Collaboration Accelerating Cancer Treatments
OBIO Member, the Centre for the Commercialization of Antibodies and Biologics (CCAB) and OBIO Partner, the National Research Council of Canada (NRC) have put in place over $1M in collaborative agreements over the past year to produce and test therapeutic antibodies discovered at the University of Toronto (U of T).
CAAP Company: Eve Medical
Former OBIO CAAP company, has announced the launch of Canada’s first HPV at home screening service
CAAP Company: CellAegis Devices Announces US$9.5 Million Financing
CellAegis Devices has announced $9.5 Million US financing to support clinical and regulatory advancement of their autoRIC® Device.
CAAP Company: Conavi Medical Announces Health Canada Approval
Conavi Medical, has announced Health Canada approval of their Foresight Intracardiac Echocardiography (ICE) System™.
Pre-CAAP Company: MedStack Joins OBIO as a New Benefit Provider
OBIO is excited to welcome MedStack as part of OBIO's Member Benefit Package!
CAAP Company: SYNG Pharmaceuticals Chosen to Attend the Biocom Global Life Science Partnering Conference
Former OBIO CAAP company Syng Pharmaceuticals, will be attending the BIOCOM Global Pharma Partnering Conference this week
Pre-CAAP Company: MedStack Announces First Two Healthcare App Integrations
MedStack Inc., the Platform for App-Enabled Healthcare, announced at the 2017 HIMSS Annual Conference & Exhibition that its integrated native FHIR database API is now employed by healthcare app companies
CAAP Company: QoC Health are Hiring
QoC Health are hiring for 3 positions: Senior Android Developer, Senior Front End Developer, Senior iOS Developer
2017 TECHNA Rounds Begin
Liberating Health Data from the Outside Thursday February 23rd 2017 5-6pm
CAAP Company: BrainFx is Hiring
OBIO CAAP company, BrainFx, is looking to hire a Senior Software Developer, apply today!
CALL FOR APPLICATIONS to Meet with Motorola Solutions Venture Capital
The Canadian Trade Commissioner Service in Chicago has organized an opportunity to present and pitch your company to Motorola Solutions Inc (MSI) and Motorola Solutions Venture Capital (MSVC). in Waterloo.
2016 Strategic Hospital Priorities Study - White Paper Available
2016 L.E.K. Strategic Hospital Priorities Study” examines the current direction of the industry and, in particular, how medtech companies can capitalize on the many needs of hospital administrators.